Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Andrew South and Matthew Sparks.
Connection Strength

1.948
  1. Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic. Nat Rev Nephrol. 2020 06; 16(6):305-307.
    View in: PubMed
    Score: 0.885
  2. Renin-angiotensin system blockade in the COVID-19 pandemic. Clin Kidney J. 2021 Mar; 14(Suppl 1):i48-i59.
    View in: PubMed
    Score: 0.232
  3. Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices. Hypertension. 2020 11; 76(5):1350-1367.
    View in: PubMed
    Score: 0.226
  4. Rigor before speculation in COVID-19 therapy. Am J Physiol Lung Cell Mol Physiol. 2020 05 01; 318(5):L1027-L1028.
    View in: PubMed
    Score: 0.220
  5. Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19. Clin J Am Soc Nephrol. 2020 May 07; 15(5):714-716.
    View in: PubMed
    Score: 0.218
  6. Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System. Adv Chronic Kidney Dis. 2020 09; 27(5):404-411.
    View in: PubMed
    Score: 0.056
  7. Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19". Circ Res. 2020 06 05; 126(12):e140-e141.
    View in: PubMed
    Score: 0.055
  8. Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology. J Am Soc Nephrol. 2020 07; 31(7):1380-1383.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.